Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
19.44
+1.60 (8.97%)
May 20, 2026, 3:35 PM EDT - Market open
Zenas BioPharma Market Cap
Zenas BioPharma has a market cap or net worth of $1.23 billion as of May 20, 2026. Its market cap has increased by 161.01% in one year.
Market Cap
1.23B
Enterprise Value
752.95M
1-Year Change
161.01%
Ranking
Category
Stock Price
$19.44
Market Cap Chart
Since the IPO on September 13, 2024, Zenas BioPharma's market cap has increased from $676.47M to $1.23B, an increase of 81.43%. That is a compound annual growth rate of 42.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 1.13B | -42.21% |
| Dec 31, 2025 | 1.95B | 469.46% |
| Dec 31, 2024 | 342.27M | -49.40% |
| Sep 13, 2024 | 676.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.20B |
| Septerna | 1.19B |
| DBV Technologies | 1.13B |
| Olema Pharmaceuticals | 1.13B |
| Avalyn Pharma | 1.11B |
| Jade Biosciences | 1.09B |
| Inventiva | 1.06B |
| Maravai LifeSciences Holdings | 1.05B |